How Covid-19 Is Changing the Future of Vaccines
In his December 24, 2020, video report,1,2 “The Future of Vaccines,” investigative journalist James Corbett reviews how the novel COVID-19 vaccine is paving the way for nonconsensual medical experimentation on the general public.
As noted by Corbett, if the international medical establishment get their way, nothing will get back to “normal” until world health officials have definitively determined there is an effective COVID vaccine in place.
Even then, however, things may not go back to the normal we’re accustomed to or expect. Since the beginning of the pandemic, world leaders have warned that social distancing, mask wearing, travel restrictions and other measures will become part of our “new normal.”3
Be that as it may, the refrain we keep hearing from the likes of Bill Gates, Dr. Anthony Fauci and a long list of other world leaders is that any sense of normalcy will remain elusive until or unless the entire global population gets vaccinated against SARS-CoV-2.
Brave New World of Vaccines
“The public is being prepared for an unprecedented global vaccination campaign,” Corbett says. However, one major problem with this is that the current COVID-19 vaccines are still in the experimental stage. While they’ve been granted emergency use authorization, they still haven’t completed Stage 3 clinical trials. Data for some end points won’t even be collected until 24 months after injection.
Another problem is that the COVID vaccines’ adverse side effects are still relatively unknown due to the “fanatical” warp speed at which they were developed.
Even if there is only one serious event per 1,000 people, cumulatively that would equate to 100,000 people being harmed by the vaccine for every 100 million vaccinated — a steep price for an infection that has an overall noninstitutionalized infection fatality rate of just 0.26%.4 Among those under the age of 40, the infection fatality rate is a mere 0.01%, which is lower than that for seasonal influenza.5
A third issue that Corbett homes in on in his report is the fact that the COVID-19 vaccines are “unlike any vaccines that have ever been used on the human population before,” and “as radically different as these vaccines appear, they represent only the very beginning of a complete transformation of vaccine technology that is currently taking place in research labs across the planet.”6
Are COVID-19 Vaccines Really as Effective as Advertised?
On an important side note, while Pfizer’s and Moderna’s vaccines have reported very high success rates, their “success” is only measured by their ability to lessen moderate to severe COVID-19 symptoms such as cough and headache. Presumably, this would lower the risk of hospitalization and death for vaccinated individuals.
However, as explained in “How COVID-19 Vaccine Trials Are Rigged,” the vaccines were not evaluated for their ability to actually prevent infection and transmission of the virus. So, since the vaccine cannot reduce infection, hospitalizations or deaths, it cannot create vaccine-acquired herd immunity and end the pandemic, even though this has been the vaccine’s primary selling point. Furthermore, as noted by Corbett:7
“The studies are touted as involving tens of thousands of people, but in Pfizer’s trial, only 170 of them were reported as being ‘diagnosed with COVID-19’ during the trial. Of those, 162 were in the placebo group and eight were in the vaccine group.
From this, it is inferred that the vaccine prevented 154/162 people from developing the disease, or ‘95%.’ But as even the British Medical Journal points out,8 ‘a relative risk reduction is being reported, not absolute risk reduction, which appears to be less than 1%.’”
COVID-19 Ushers in a Whole New Breed of Vaccines
Getting back to the main point of the Corbett report, the COVID-19 vaccines under development are unlike any other vaccine ever released. They’re mRNA vaccines, and do not work like conventional vaccines. In summary, RNA are molecules that encode certain proteins. The RNA used in COVID-19 vaccines encode for the SARS-CoV-2 spike protein.
The idea is that by injecting this RNA, your own cells will start to produce and secrete the SARS-CoV-2 spike protein. Your immune system will then respond to the presence of that viral protein by producing antibodies. It’s important to realize that this technology is entirely unproven, and there’s no telling how this RNA programming might affect your health in years to come. As explained by Corbett:9
“The term ‘vaccination’ … came to refer to the general process of introducing immunogens or attenuated infectious agents into the body in order to stimulate the immune system to fight infections. But this is not how mRNA vaccines function.
In contrast to vaccination, which involves introducing an immunogen into the body, mRNA vaccines seek to introduce messenger RNA into the body in order to ‘trick’ that body’s cells into producing immunogens, which then stimulate an immune response …
Despite the straw man argument that opposition to the vaccine comes solely from ignorant members of the public who are worried about being ‘injected with mircochips,’ there are genuine concerns about the long-term safety of these vaccines coming from within the scientific community, and even from whistleblowers from within the ranks of the Big Pharma manufacturers themselves.”
December 1, 2020, two such whistleblowers — Dr. Wolfgang Wodarg, former chair of the Parliamentary Assembly of the Council of Europe Health Committee, and Dr. Michael Yeadon, former vice-president and chief scientific officer at Pfizer Global R&D — filed a petition10 calling on the European Medicine Agency to halt Phase 3 clinical trials of the Pfizer mRNA vaccine until they’ve been restructured to address critical safety concerns.
Key Safety Concerns
The four key safety concerns specified in the petition11 to the European Medicine Agency are:
1.The potential for formation of non-neutralizing antibodies that can trigger an exaggerated immune reaction (referred to as paradoxical immune enhancement or antibody-dependent immune amplification) when the individual is exposed to the real “wild” virus post-vaccination.
Antibody-dependent amplification has been repeat
Article from LewRockwell